HGH Fragment 176-191 is a specialized synthetic modification of the C-terminal region of human growth hormone, explicitly isolated to harness specific metabolic traits. It is classified strictly as a targeted lipolytic peptide because research suggests it mimics the fat-oxidation pathways of full-length growth hormone without affecting serum glucose, altering insulin sensitivity, or driving cellular proliferation. Because lipolysis acceleration is associated with vital physiological activities, this compound is heavily utilized in metabolic research to analyze fat-cell destruction profiles (apoptosis) and track energy expenditure shifts. Sterilely filtered and vacuum-packaged to ensure absolute sequence identity across variable reconstitution intervals.
-
Note: Distributed strictly for in-vitro scientific research and laboratory calibration.
Reviews
There are no reviews yet.